Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Spleen ultrafiltrate imparts favorable effects in chemotherapy recipients

Jan. 7, 1998

Native calcitonin mimetics from ZymoGenetics

Jan. 5, 1998

Lilly discovers potent, selective and orally active beta3 agonists for diabetes, obesity

Jan. 2, 1998

Akzo Nobel describes new gonadotropins with therapeutic potential

Jan. 2, 1998

OGT-918 clinical development program begins

Dec. 30, 1997

Pfizer discovers potent, orally active human liver glycogen phosphorylase inhibitor

Dec. 30, 1997

S-22068: effects on glucose tolerance and plasma insulin in mice

Dec. 30, 1997

Boehringer Mannheim presents new calcium regulators

Dec. 30, 1997

FDA approval obtained for Prandin

Dec. 29, 1997

Otsuka's new antidiabetic agents

Dec. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...